Blog

Sherene Loi: Long-Term affects of Adjuvant Breast Cancer Treatment on Lymphocyte Counts

industry.gov.au

Nov 1, 2024, 11:28

Sherene Loi: Long-Term affects of Adjuvant Breast Cancer Treatment on Lymphocyte Counts

Sherene Loi, Medical Oncologist, Lab Head of Breast Oncology Clinical Trials at Peter MacCallum Cancer Centre, shared on X:

“Sharing our latest article: Here we show that dose dense AC-T, radiotherapy and age affects long-term lymphocyte counts post adjuvant breast cancer treatment ?implications for IO therapy.”

Sustained lymphocyte decreases after treatment for early breast cancer

Authors: Julia Dixon-Douglas, Balaji Virassamy, Kylie Clarke, Michael Hun, Stephen J. Luen, Peter Savas, Courtney T. van Geelen, Steven David, Prudence A. Francis, Roberto Salgado, Stefan Michiels, Sherene Loi

Sherene Loi

More posts featuring Immunotherapy on oncodaily.com

Balaji Virassamy cancer Courtney T. van Geelen Julia Dixon-Douglas Kylie Clarke Michael Hun OncoDaily Oncology Peter Savas Prudence A. Francis radiotherapy Roberto Salgado Sherene Loi Stefan Michiels Stephen J. Luen Steven David

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action